Review of rituximab in chop chemotherapy with chop only chemotherapy in treating aggressive Non Hodgkin's Lymphoma in elderly patients / Hazwan Ab Hamid

Ab Hamid, Hazwan (2013) Review of rituximab in chop chemotherapy with chop only chemotherapy in treating aggressive Non Hodgkin's Lymphoma in elderly patients / Hazwan Ab Hamid. Degree thesis, Universiti Teknologi MARA (Kampus Puncak Alam).
Abstract

Background: The diffuse large B-cell lymphoma is a type of aggressive Non­ Hodgkin' s lymphoma (NHL) that is commonly found in elderly patients. CHOP chemotherapy has been used to treat this aggressive lymphoma. CHOP has brought several toxicities to patients especially to the elderly aggressive NHL patients. New combination of chemo drug, rituximab was introduce lately and brings an impact to the old CHOP chemotherapy. Its efficacy is known better from CHOP only regimen. Method: Journals containing articles that are relevant to the subject of efficacy of rituximab in CHOP chemotherapy are gathered and systematic review and analysis was done to extract the information. Results: Several articles supported the hypothesis and confirmed its efficacy compared to CHOP only chemotherapy. And its toxicity towards the elderly patients is relevant. Conclusion: Rituximab plus CHOP is proven better than CHOP only chemotherapy in the term of its efficacy.

Item Details
Edit Item
Edit Item
Downloads & Files
[thumbnail of 109522.PDF]
Text
109522.PDF
Download (1MB)
Location & Physical Holdings
Digital Copy
Physical Location
  • Bilik Koleksi Harta Intelek, Unit Terbitan Bersiri dan Elektronik | PTAR Puncak Alam
Item Status
On Shelf
Indexing & Metrics